ReviewDiabetes2012
Through the fog: recent clinical trials to preserve β-cell function in type 1 diabetes.
Review in Diabetes, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes.Genes and immunity · 2019Trial
- Article
- The β-Cell in Type 1 Diabetes Pathogenesis: A Victim of Circumstances or an Instigator of Tragic Events?Diabetes · 2022Review
- A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes.Immunotherapy advances · 2022Article
- Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanism.Frontiers in endocrinology · 2022Article
- Article
- Review
- Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.International journal of molecular sciences · 2021Review
- C-peptide and residual β-cell function in pediatric diabetes - state of the art.Pediatric endocrinology, diabetes, and metabolism · 2021Review
- Presumption of innocence for beta cells: why are they vulnerable autoimmune targets in type 1 diabetes?Diabetologia · 2020Review
- Cell type-specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes.JCI insight · 2019Article
- B lymphocyte alterations accompany abatacept resistance in new-onset type 1 diabetes.JCI insight · 2019Article
- Article
- Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans.PloS one · 2018Article
- Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes.PloS one · 2017Article
- Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes.Science immunology · 2016Article
- Beta cell antigens in type 1 diabetes: triggers in pathogenesis and therapeutic targets.F1000Research · 2016Review
- Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes.Diabetes · 2015Article
- Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease.Diabetes care · 2015Article
- Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice.Clinical and experimental immunology · 2015Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.